Our People
Our People

Our People

Our mission at Curie Therapeutics is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.

Curie is a fully integrated next generation radiopharmaceutical company that comprises experts in ligand discovery, radiochemistry, radiobiology, and oncology translational and clinical research, building a pipeline across a range of solid tumor types, with clinical entry targeted 2023.